Alpine Immune Sciences, Inc.
NASDAQ:ALPN
64.97 (USD) • At close May 17, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -32.184 | -57.762 | -50.333 | -27.94 | -41.852 | -36.487 | -7.783 | -31.463 | -22.818 | -15.036 | -16.198 | -9.573 |
| Afschrijvingen & Amortisatie
| 0.576 | 0.597 | 0.62 | 0.578 | 0.468 | 0.388 | 0.241 | 0.143 | 0.066 | 0.086 | 0.219 | 0.212 |
| Uitgestelde Inkomstenbelasting
| 0.155 | 0.046 | 0.91 | 0.108 | -0.344 | -0.305 | -0.204 | -3.263 | -1.343 | -0.294 | -0.009 | -0.15 |
| Aandelen Gebaseerde Vergoedingen
| 10.63 | 9.648 | 6.24 | 4.14 | 3.041 | 0 | 0.838 | 3.263 | 1.343 | 0.07 | 0.098 | 0.018 |
| Verandering in Werkkapitaal
| -50.161 | 4.192 | 27.041 | 52.937 | 3.201 | 4.671 | -3.354 | 1.798 | 2.202 | 0.018 | 1.076 | -0.206 |
| Vorderingen
| 0.225 | 24.602 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 6.519 | 5.557 | 5.97 | -0.491 | 0.816 | 1.523 | 0.066 | 0.927 | 0.065 | 0.258 | 0.4 | 0.111 |
| Overig Werkkapitaal
| -56.905 | -25.967 | 21.071 | 53.428 | 2.385 | 3.148 | -3.42 | 0.871 | 2.137 | -0.24 | 0.676 | -0.317 |
| Overige Niet-Contante Posten
| -8.028 | -0.475 | 0.274 | 0.261 | 0.14 | 1.008 | -6.31 | 3.263 | 1.343 | 0.709 | 0.521 | 0.181 |
| Kasstroom uit Operationele Activiteiten
| -79.012 | -43.754 | -15.248 | 30.084 | -35.346 | -28.416 | -16.572 | -26.259 | -19.207 | -14.448 | -14.293 | -9.518 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.487 | -0.412 | -0.118 | -0.802 | -0.821 | -0.495 | -0.586 | -0.106 | -0.188 | -0.004 | -0.125 | -0.03 |
| Netto Overnames
| 0 | 112.936 | 52.362 | 72.017 | -17.584 | 0 | 31.13 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -351.347 | -266.984 | -133.518 | -101.328 | -59.382 | -72.863 | -88.307 | -75.324 | -76.26 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 296.275 | 154.048 | 81.156 | 29.311 | 76.966 | 105.226 | 27.96 | 100.735 | 14 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | -112.936 | -52.362 | -72.017 | 17.584 | 0.25 | 31.13 | 0 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -55.559 | -113.348 | -52.48 | -72.819 | 16.763 | 32.118 | -29.803 | 25.305 | -62.448 | -0.004 | -0.125 | -0.03 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 168.547 | 106.716 | 102.662 | 56.258 | 23.598 | 0.009 | 37.666 | 0.02 | 78.771 | 11.868 | 12 | 2 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 165.122 | 102.689 | 100.764 | 61.381 | 24.255 | -0.991 | 42.688 | 0.166 | 78.834 | 41.166 | 10.811 | 11.663 |
| Kasstroom uit Financieringsactiviteiten
| 165.122 | 102.689 | 100.764 | 61.381 | 24.255 | -0.991 | 42.688 | 0.166 | 78.834 | 41.166 | 10.811 | 11.663 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.008 | -0.118 | -0.088 | 0.058 | -0.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 30.559 | -54.531 | 32.948 | 18.704 | 5.666 | 2.711 | -3.687 | -0.788 | -2.821 | 26.714 | -3.607 | 2.115 |
| Kaspositie aan het Einde van de Periode
| 44.189 | 13.63 | 68.161 | 35.213 | 16.509 | 10.843 | 8.132 | 24.203 | 24.991 | 27.812 | 1.098 | 4.705 |